October 17, 2019 - Page 21 of 21

NYSE Companies - October 17, 2019

Female Forward Together, a Cross-Sector Coalition, Announced to Advance Research, Education, and Action for Women’s Health

BRISBANE, Calif., and BASEL, Switzerland, Oct. 17, 2019 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing […]

NYSE Companies - October 17, 2019

First-of-Its-Kind Nationwide Survey from Myovant Sciences and Evidation Health Captures Impact of Menstrual Stigma and Symptoms

BASEL, Switzerland and SAN MATEO, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) — Pervasive stigma and prevalent symptoms related to menstruation […]

Canadian Stock Exchange News - October 17, 2019

AgraFlora Organics se prépare pour l’entrée en vigueur ce 17 octobre de la nouvelle réglementation de Santé Canada portant sur les produits comestibles, les extraits et les produits topiques à base de cannabis, avec des dépenses en immobilisations corporelles liées à son portefeuille d’actifs de cannabis 2.0 totalisant 85 millions de dollars canadiens

VANCOUVER, Colombie-Britannique, 17 oct. 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: [...]

Canadian Stock Exchange News - October 17, 2019

AgraFlora Organics Prepares for October 17th Health Canada Edibles, Extracts and Topicals Regulations with Over C$85 Million in Dedicated PPE Expenditures Related to Cannabis 2.0 Asset Portfolio

VANCOUVER, British Columbia, Oct. 17, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) […]

NASDAQ Companies - October 17, 2019

Chi-Med highlights publication of Phase II data showing promising efficacy for Savolitinib in MET-amplified gastric cancers

LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today highlighted the publication of results […]

NASDAQ Companies - October 17, 2019

Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD

LONDON, Oct. 17, 2019 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused […]